rfhg_165427.1

Basic information about the TSS

---

TSS ID: rfhg_165427.1 Species: human Chr: chr14		Start: 39041391 End: 39041408 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000554615.1:-25 AL137739:-25 GeneID: 10484 HGNC/MGI_ID: HGNC:10701 UniProt_ID: Nearer transcript ids and distances: ENST00000555363.1:147

Gene_name: SEC23 homolog A, COPII coat complex component Gene_symbol: SEC23A Gene_synonyms: Gene_source: HGNC:10701

TATA-Box annotation

---

Distance to TSS:	-61741
Nearest PromoterID:	NR_146545
Entrez ID:	105370458
Nearest Unigene:
Nearest Refseq:	NR_146545
Nearest Ensembl:	ENSG00000258651
Gene Name:	SEC23 homolog A, COPII coat complex component
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.222222
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SEC23A p2@SEC23A p3@SEC23A p4@SEC23A
Sample		p1@SEC23A	p2@SEC23A	p3@SEC23A	p4@SEC23A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	36.23	3.31	0.00	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	31.76	4.25	0.40	2.43
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.74	4.44	0.19	2.89
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.81	1.66	0.21	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	32.85	2.25	0.00	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.16	1.16	0.39	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	49.90	3.92	0.87	5.66
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	37.30	4.60	0.00	4.12
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	40.39	2.35	0.43	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	43.47	5.22	0.00	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.04	4.04	0.00	3.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.84	4.88	0.41	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	47.87	0.97	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	35.93	0.60	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	43.69	1.32	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	35.21	1.51	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.54	1.31	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	34.59	0.84	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	41.05	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.73	0.75	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.83	0.53	0.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	44.02	1.55	0.35	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.74	0.78	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.73	0.97	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	34.83	1.81	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.66	0.32	1.27	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	30.22	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	47.62	0.71	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	39.57	1.29	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.60	0.54	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	28.68	1.47	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	40.83	0.78	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.72	0.42	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	44.86	1.65	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	41.89	1.31	0.19	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	44.26	1.72	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	41.08	1.84	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.06	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.95	0.54	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	46.09	1.20	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.76	0.71	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	44.50	0.59	0.29	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	48.93	0.63	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.26	0.52	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	48.99	1.81	1.41	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	51.18	1.16	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	41.74	0.72	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	52.75	1.49	0.89	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	56.97	1.68	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	55.81	2.43	1.42	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	59.44	2.66	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	74.94	2.00	0.44	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	0.00	69.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	55.00	1.42	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	58.32	2.32	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	77.18	4.19	3.36	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	79.91	2.76	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	73.25	3.24	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	64.56	0.64	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	98.07	6.29	0.94	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	54.29	3.53	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	61.69	1.68	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	98.72	9.55	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	88.68	4.76	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	64.33	1.95	0.65	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	59.99	2.84	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	0.00	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	126.36	15.79	31.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	65.33	2.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	91.24	6.45	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	83.50	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	119.23	3.64	0.33	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	89.09	1.55	0.00	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	92.03	1.53	0.00	1.22
Adipocyte - breast, donor1	11376-118A8	114.67	29.78	0.48	2.53
Adipocyte - breast, donor2	11327-117E4	83.74	21.66	0.32	1.28
Adipocyte - omental, donor1	11473-119C6	129.90	31.81	0.13	1.91
Adipocyte - omental, donor2	11474-119C7	98.67	15.70	0.00	2.24
Adipocyte - omental, donor3	11475-119C8	90.09	12.06	0.33	1.67
Adipocyte - perirenal, donor1	11476-119C9	111.65	17.86	0.00	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	12.09	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	62.78	13.55	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	43.27	6.60	0.00	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	126.14	21.90	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	87.77	15.44	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	116.53	17.56	0.00	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	112.86	27.63	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	130.22	50.11	0.88	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	80.04	22.92	0.00	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	73.05	23.99	0.00	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	100.16	33.94	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	72.37	33.27	0.00	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	56.51	18.84	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	76.25	29.12	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	81.60	37.15	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	31.16	2.21	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	14.70	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	41.20	2.88	0.00	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	26.91	4.31	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	108.70	7.32	0.11	0.46
Anulus Pulposus Cell, donor2	11463-119B5	101.39	2.69	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	64.25	7.19	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	73.37	9.99	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	57.79	12.84	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	63.37	9.27	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	60.70	12.65	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	47.53	6.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	67.25	6.82	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	86.89	8.74	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	62.36	5.34	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	64.40	9.79	0.00	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	65.31	10.89	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	58.93	11.28	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	96.37	14.33	0.16	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	54.59	10.92	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	85.50	12.36	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	66.44	10.18	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	89.93	11.15	0.00	2.08
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	74.31	9.62	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	60.48	6.83	0.00	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	82.60	10.78	0.00	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	58.84	4.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	77.88	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	76.50	8.40	0.17	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	58.73	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	75.24	10.68	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	83.48	14.42	0.38	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	53.30	7.27	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	73.53	11.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	72.90	10.69	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	63.49	11.10	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	66.63	7.51	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	70.10	7.72	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	64.21	7.85	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	59.67	9.36	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	71.66	9.94	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	74.84	14.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	57.98	11.19	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	75.13	12.99	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	51.46	11.44	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	77.68	9.93	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	74.73	11.64	0.00	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	57.13	8.12	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	58.57	6.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	77.64	9.49	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	60.23	9.27	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	78.17	12.68	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	78.90	8.36	0.21	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	71.00	7.22	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	61.23	8.75	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	81.15	10.57	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	99.66	12.46	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	97.03	13.21	0.21	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	66.40	11.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	76.00	11.95	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	82.71	10.42	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	48.83	4.58	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	83.64	4.43	0.00	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	86.32	12.45	0.00	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	61.79	7.63	0.00	1.45
Astrocyte - cerebellum, donor1	11500-119F6	41.27	0.98	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	43.30	1.54	0.34	1.54
Astrocyte - cerebellum, donor3	11661-122F5	17.41	0.84	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	78.78	2.44	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	74.09	6.79	0.65	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	96.21	10.74	0.45	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	46.91	1.03	1.15	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.72	1.38	0.88	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.82	1.25	0.68	1.48
Basophils, donor1	12241-129G9	20.92	1.31	0.52	0.00
Basophils, donor2	12242-129H1	48.35	2.53	0.36	0.00
Basophils, donor3	12243-129H2	24.70	1.62	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	11.64	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	35.78	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	25.16	2.08	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	30.17	0.69	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	34.73	1.44	0.18	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.44	0.82	0.00	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	35.40	1.63	0.70	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	31.34	2.24	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	1.13	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	19.30	1.30	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	28.54	1.98	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	51.80	0.57	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	60.65	2.27	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.86	1.31	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	19.95	1.45	0.29	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	17.80	0.91	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	25.35	1.42	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.74	0.84	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.18	1.10	0.55	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.10	0.50	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.92	1.17	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.71	0.53	0.36	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	21.76	1.09	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.45	1.17	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.37	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	19.97	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.09	1.78	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	12.37	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.86	2.08	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.70	1.60	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.81	1.36	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.84	1.31	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	19.10	1.88	0.00	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.79	0.87	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	1.26	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.82	0.37	0.00	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.91	1.06	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.04	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.60	1.74	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.75	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.68	1.29	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.28	0.82	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.98	1.16	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.92	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	27.90	1.53	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	22.18	1.39	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	28.81	0.87	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	39.55	2.02	0.16	1.71
CD14+CD16- Monocytes, donor2	11799-124C8	30.39	1.22	0.17	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	60.20	3.12	0.45	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	21.95	2.55	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	21.30	2.85	0.66	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	25.90	1.68	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	50.17	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	40.39	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	62.37	1.60	1.07	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	60.04	1.61	0.54	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	54.75	0.70	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	48.63	2.35	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	48.78	2.64	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	61.64	1.64	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	42.80	0.73	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	48.46	2.02	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	5.66	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.40	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	19.08	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	44.94	4.49	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.18	2.63	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	33.60	2.71	0.23	0.68
CD4+ T Cells, donor1	11225-116C1	68.20	0.71	1.07	1.79
CD4+ T Cells, donor2	11306-117C1	60.01	1.84	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	60.08	1.52	2.13	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.09	2.55	0.00	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.53	1.35	1.12	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	52.03	1.72	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	64.00	4.74	0.00	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	71.64	1.40	0.70	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	44.94	1.30	0.58	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	38.47	0.51	0.85	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.04	0.97	1.45	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	51.55	0.45	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	54.50	1.05	0.00	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	69.96	3.08	0.00	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	57.34	3.37	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.80	1.04	2.49	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	42.43	1.34	1.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	75.05	2.72	0.54	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	77.71	1.61	1.61	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	64.56	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	62.86	0.93	0.37	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	43.97	2.38	2.82	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	46.02	2.52	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	62.69	3.03	0.00	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	57.62	0.87	0.43	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	83.68	2.61	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	85.12	0.99	1.48	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	83.09	0.00	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	67.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	96.37	0.83	0.00	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	116.32	1.96	0.74	3.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	95.48	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	80.22	2.86	1.79	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	80.33	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	63.84	4.58	0.65	0.98
CD8+ T Cells, donor2	11307-117C2	56.31	4.13	1.88	1.50
CD8+ T Cells, donor3	11383-118B6	60.85	2.52	1.51	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.35	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.81	1.20	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.15	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.01	1.20	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.36	1.44	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.24	0.68	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.25	0.65	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.58	1.32	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	17.82	1.17	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.92	0.91	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.27	0.00	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	24.78	1.60	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.70	2.19	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.24	3.19	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.11	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.55	0.86	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.32	0.47	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.28	0.63	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	17.53	0.92	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.16	1.92	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.39	1.15	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	22.46	1.18	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	17.40	1.51	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	2.41	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	0.70	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	31.07	5.48	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	74.11	10.87	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	101.02	19.26	0.11	1.16
Chondrocyte - de diff, donor1	11261-116G1	95.33	7.63	0.69	3.12
Chondrocyte - de diff, donor2	11338-117F6	70.01	2.84	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	60.30	6.83	0.00	1.37
Chondrocyte - re diff, donor2	11339-117F7	126.23	8.95	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	105.95	8.09	1.21	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	100.76	5.28	0.23	1.95
Ciliary Epithelial Cells, donor2	11323-117D9	100.04	10.26	0.00	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	108.68	10.27	0.71	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	58.23	2.84	1.19	6.97
Corneal Epithelial Cells, donor1	11526-119I5	10.10	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	10.74	0.51	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	51.51	1.65	0.33	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	50.15	3.47	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	35.74	1.19	0.22	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	73.45	4.10	0.00	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	72.47	5.88	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	99.69	2.90	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	71.54	5.34	0.17	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	46.94	1.76	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	77.77	4.24	0.00	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	69.20	5.90	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	40.72	2.04	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	57.88	5.18	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	62.76	5.61	0.18	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	76.69	7.31	0.44	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	81.85	7.30	0.91	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	97.54	9.87	0.85	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	51.11	2.97	0.59	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	61.44	8.33	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	31.19	3.12	0.28	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	99.23	4.00	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	45.07	7.34	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	129.34	12.80	0.87	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	121.01	8.47	0.00	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	134.83	10.75	0.00	1.59
Endothelial Cells - Vein, donor1	11267-116G7	51.19	6.83	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	55.18	4.19	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	67.51	4.24	0.00	1.10
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	57.76	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	32.10	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.46	0.49	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	140.40	23.81	0.00	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	39.74	5.91	0.00	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.71	7.80	0.00	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	107.58	22.44	0.12	1.82
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	150.53	29.75	1.64	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	81.32	11.18	0.32	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	90.64	10.01	0.53	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	83.38	11.96	0.00	1.99
Fibroblast - Cardiac, donor1	11268-116G8	88.91	14.97	0.45	1.81
Fibroblast - Cardiac, donor2	11345-117G4	97.78	20.46	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	43.69	6.47	0.00	0.47
Fibroblast - Cardiac, donor4	11452-119A3	129.43	22.73	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	97.59	8.76	1.02	1.52
Fibroblast - Cardiac, donor6	11460-119B2	104.15	13.19	0.76	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	83.74	7.37	0.00	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	121.23	14.24	0.43	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	101.07	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	26.98	0.46	0.00	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	109.56	13.06	0.34	2.37
Fibroblast - Dermal, donor1	11269-116G9	70.20	8.45	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	47.17	3.30	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	60.68	7.62	0.12	1.33
Fibroblast - Dermal, donor4	11450-119A1	124.80	5.77	0.45	2.71
Fibroblast - Dermal, donor5	11454-119A5	129.62	6.63	0.17	1.92
Fibroblast - Dermal, donor6	11458-119A9	161.45	8.77	0.32	2.76
Fibroblast - Gingival, donor1	11237-116D4	131.60	15.62	1.04	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	172.13	23.32	0.26	2.88
Fibroblast - Gingival, donor2	11318-117D4	108.59	10.41	0.53	1.19
Fibroblast - Gingival, donor3	11394-118C8	99.88	10.06	0.29	2.03
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	91.42	10.39	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	86.87	11.81	0.00	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	167.12	27.91	0.00	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	129.68	20.42	0.27	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.94	5.29	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	206.79	34.51	0.73	2.19
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	197.03	38.04	0.14	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	167.17	24.24	0.11	3.07
Fibroblast - Gingival, donor9 (control)	11927-125I1	136.61	19.22	0.15	2.49
Fibroblast - Lung, donor1	11270-116H1	40.78	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	110.42	4.48	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	70.70	2.32	0.00	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	48.32	1.67	0.00	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	2.80	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	13.15	1.68	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	79.57	7.71	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	23.97	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	163.33	13.38	1.36	2.33
Fibroblast - Periodontal Ligament, donor2	11319-117D5	164.57	11.07	0.76	3.19
Fibroblast - Periodontal Ligament, donor3	11395-118C9	171.66	26.31	0.31	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	149.60	12.21	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	111.78	18.63	0.00	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	105.42	11.02	0.12	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	95.94	19.79	0.22	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	62.99	4.27	0.41	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.07	2.00	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	93.31	9.88	0.00	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	179.20	25.80	0.79	2.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	103.20	9.59	0.00	2.84
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	129.88	18.13	0.39	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	139.90	25.57	1.81	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	152.54	16.73	0.65	3.02
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	187.28	27.33	0.51	4.30
Fibroblast - skin normal, donor1	11553-120C5	129.95	18.21	0.16	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	171.23	36.89	3.21	2.61
Fibroblast - skin normal, donor2	11561-120D4	159.84	22.40	0.40	2.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	230.61	30.53	0.91	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	131.39	14.17	0.58	1.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	158.13	15.73	0.85	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	160.93	29.89	0.99	2.96
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	161.59	29.93	0.43	1.81
Fibroblast - skin walker warburg, donor1	11554-120C6	131.74	15.35	0.00	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	94.41	21.95	0.00	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	4.36	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	53.39	4.68	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	81.98	10.15	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	60.30	3.07	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	42.11	3.83	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.28	6.38	0.64	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	60.19	7.42	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.53	3.86	1.38	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	38.59	3.42	0.68	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.56	3.57	0.20	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	38.33	2.11	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	40.12	3.59	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	60.14	6.19	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.14	3.25	0.14	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	53.57	3.20	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	32.24	4.57	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.54	3.59	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	42.36	3.46	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	31.51	5.08	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	48.15	4.11	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	41.36	3.61	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.87	4.59	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.07	5.32	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	55.64	5.09	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.11	4.24	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	53.43	6.65	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	64.46	5.94	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	69.87	8.34	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.26	4.58	0.52	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.09	3.76	0.34	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	71.04	5.75	0.22	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	72.88	8.90	0.33	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	71.67	8.78	0.20	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	63.34	5.16	0.21	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	77.36	4.38	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.70	6.67	0.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	53.34	4.41	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	71.09	4.06	0.25	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	56.57	4.86	0.65	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	78.58	4.17	0.00	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	60.55	4.07	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	60.11	3.64	0.16	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	53.52	4.56	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	61.68	3.55	0.10	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	66.74	3.07	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	56.11	2.81	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	71.85	6.11	0.19	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	50.54	4.81	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	58.60	5.81	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	63.34	5.18	0.26	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	81.59	4.88	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	67.29	7.93	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	70.62	7.46	0.22	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	72.40	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	88.64	9.76	0.40	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	89.18	12.91	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	70.15	10.42	0.00	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	71.86	7.56	0.60	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	50.07	3.08	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	62.40	2.25	0.20	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.10	3.13	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	30.80	2.54	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.04	3.69	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	30.94	5.03	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	44.93	11.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.62	6.51	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	39.94	6.59	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	10.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	37.47	7.83	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	38.24	6.86	1.31	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	35.23	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	46.12	6.36	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.08	6.79	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	57.27	6.30	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.93	5.33	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	6.78	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	57.16	10.36	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	43.49	5.75	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	10.54	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	55.36	8.84	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.57	7.82	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.86	4.68	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	65.11	4.62	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	96.88	10.61	2.74	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	74.08	3.77	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	74.23	9.05	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	83.93	6.10	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	67.00	5.98	1.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	98.18	4.93	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	92.07	9.44	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	67.68	9.92	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	105.33	9.66	2.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	78.84	7.63	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	59.69	9.55	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	56.29	9.22	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	93.59	21.68	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	71.94	8.73	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	68.59	9.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.11	8.56	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	38.01	10.44	0.00	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	44.91	4.64	0.00	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	47.10	5.57	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	43.91	4.55	0.00	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	41.32	4.92	0.22	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	46.21	3.65	0.21	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	42.84	5.17	0.22	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	45.71	5.85	0.12	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	45.63	8.06	0.17	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	46.77	3.84	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	37.49	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.07	1.30	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	10.58	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	55.38	3.53	0.00	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	24.70	4.36	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	68.54	14.86	0.17	1.22
Hepatocyte, donor1	11523-119I2	87.16	39.95	2.42	1.21
Hepatocyte, donor2	11603-120I1	107.73	39.86	0.00	0.00
Hepatocyte, donor3	11684-122I1	123.93	26.38	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	34.59	0.65	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	87.92	27.09	0.52	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	91.38	11.25	0.27	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	2.65	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	1.11	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	0.00	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.27	0.65	0.00	4.52
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.85	0.00	0.00	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	14.47	1.61	0.00	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	0.92	0.00	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	0.00	0.00	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	0.00	0.00	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.14	0.71	0.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.26	0.00	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	0.00	0.00	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.21	0.00	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	2.25	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	0.00	0.00	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	0.00	0.00	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	0.00	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	35.74	3.84	0.08	0.57
Keratinocyte - epidermal, donor2	11349-117G8	19.33	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	45.06	1.70	0.19	0.76
Keratinocyte - oral, donor1	11251-116E9	61.41	2.50	0.11	1.48
Keratocytes, donor1	11527-119I6	29.23	1.03	0.00	0.69
Keratocytes, donor2	11607-120I5	36.33	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	46.44	3.75	0.20	1.98
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	63.65	5.39	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	73.24	3.81	0.23	0.69
Lens Epithelial Cells, donor3	11690-122I7	156.91	25.03	0.00	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	48.50	3.68	0.12	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.07	1.67	0.28	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	52.89	4.56	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	36.03	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.00	2.52	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.58	1.51	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	38.17	1.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	15.17	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.74	3.10	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.95	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.32	2.33	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.26	0.93	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	40.77	3.48	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.95	1.67	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.46	1.51	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	38.49	4.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	16.52	0.94	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.70	1.28	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	38.51	3.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.23	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.43	0.75	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	34.92	4.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	33.93	1.08	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	30.28	2.27	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	31.10	3.11	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	35.39	2.51	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.76	1.80	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	33.71	3.44	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.42	1.51	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.84	0.53	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	37.80	2.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.52	1.65	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.44	1.73	0.37	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	55.90	4.07	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	25.45	2.47	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.07	1.37	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	45.35	3.86	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.69	2.74	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.83	3.64	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.60	2.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.81	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.85	0.78	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	33.30	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.75	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.59	1.65	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.50	2.60	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.86	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.99	1.19	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	0.77	0.77	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	2.97	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	20.31	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.10	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.64	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	1.19	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.66	1.58	0.45	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.19	1.45	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	2.70	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.05	1.22	0.14	1.49
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	23.62	0.51	0.51	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	19.05	2.12	0.35	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.99	0.00	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.90	1.53	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	0.80	0.27	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.10	1.89	0.38	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	3.07	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	0.82	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	25.82	1.67	0.21	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.75	0.56	0.28	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	1.03	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.93	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.70	1.20	0.00	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.79	2.77	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.39	0.71	0.35	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.60	1.48	0.37	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.96	3.07	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.68	3.40	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	18.98	1.81	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	24.42	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	1.49	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.67	1.86	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.55	2.15	0.00	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	2.57	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	25.65	1.33	0.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.93	1.21	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.75	0.71	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.18	1.37	0.34	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	30.59	2.15	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.91	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.85	1.85	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	6.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	3.17	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	26.81	1.60	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	25.44	1.45	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	3.83	0.00	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.64	2.47	0.49	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.17	1.51	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	26.14	0.45	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	19.60	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	23.85	2.35	0.00	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	1.04	0.52	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	34.13	1.31	0.88	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	0.00	0.56	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	27.82	2.21	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.53	3.09	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.32	0.51	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.59	1.44	0.48	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	23.46	1.59	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	2.43	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	21.44	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.42	1.14	0.00	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	2.07	0.00	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.74	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	21.23	0.95	0.32	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.32	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.20	3.09	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	2.83	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.29	2.27	0.57	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.13	1.25	0.00	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	23.38	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.59	1.39	0.46	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	2.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	32.08	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	24.65	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	27.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	0.00	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.93	1.71	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	0.00	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.91	1.09	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.38	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	29.89	2.34	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	24.53	1.33	0.66	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	37.61	0.68	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	46.98	2.20	0.18	0.55
Macrophage - monocyte derived, donor3	11389-118C3	39.46	1.70	0.26	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	51.51	4.78	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	123.43	10.14	0.48	0.79
Mallassez-derived cells, donor3	11930-125I4	83.39	7.23	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	47.33	3.59	0.10	1.40
Mammary Epithelial Cell, donor2	11350-117G9	53.57	2.03	0.29	1.16
Mammary Epithelial Cell, donor3	11422-118F9	23.70	2.99	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	86.78	4.07	0.00	0.68
Mast cell, donor1	11563-120D6	41.42	0.65	1.41	0.87
Mast cell, donor2	11565-120D8	46.66	0.30	0.89	0.89
Mast cell, donor3	11566-120D9	59.88	1.13	0.68	0.45
Mast cell, donor4	11567-120E1	48.93	1.24	0.53	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	62.32	0.55	1.00	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	49.61	0.00	1.17	1.75
Mast cell, expanded, donor5	11939-126A4	42.10	0.92	0.34	0.57
Mast cell, expanded, donor8	11941-126A6	29.79	0.50	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	66.17	6.47	0.10	1.09
Melanocyte - dark, donor2	11582-120F7	69.91	14.54	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	42.52	1.30	0.29	1.30
Melanocyte - light, donor1	11274-116H5	18.34	2.35	0.00	0.24
Melanocyte - light, donor2	11351-117H1	14.33	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	10.41	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	41.96	2.29	0.21	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	41.95	2.69	0.00	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	37.23	1.34	0.00	0.80
Meningeal Cells, donor1	11493-119E8	67.36	2.98	0.00	1.86
Meningeal Cells, donor2	11573-120E7	96.83	4.40	0.88	0.44
Meningeal Cells, donor3	11654-122E7	94.70	11.41	0.49	1.47
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	120.34	9.98	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	115.93	19.42	0.20	1.71
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	91.85	14.35	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	106.52	9.95	0.00	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	84.44	9.55	0.00	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	39.12	3.08	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	33.61	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	31.10	3.89	0.20	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	111.64	7.34	0.00	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.44	1.12	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	127.50	18.95	0.26	2.24
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	27.00	5.04	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	51.23	6.40	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	118.03	16.66	0.35	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	112.58	16.89	0.00	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	87.81	10.89	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	82.73	6.63	0.00	0.80
Mesothelial Cells, donor2	12156-128G5	79.07	7.01	0.00	3.00
Mesothelial Cells, donor3	11402-118D7	75.30	3.11	0.29	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	74.27	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	60.09	2.22	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	43.29	3.53	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	69.14	0.00	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.46	1.24	0.31	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	27.59	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	46.05	2.75	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.15	2.33	0.00	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	41.86	1.83	0.00	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	43.16	2.38	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	34.57	2.28	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	51.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	31.41	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.07	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	36.06	2.09	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	46.95	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	29.86	0.75	0.25	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.38	0.95	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	54.74	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	29.24	1.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.13	2.10	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.57	1.63	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	29.39	1.07	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.01	1.11	0.00	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	26.72	0.88	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	49.17	2.53	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	61.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	43.21	2.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	38.82	2.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	33.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.95	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	35.62	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.54	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	53.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	32.41	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	61.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	62.12	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	31.49	0.00	0.00	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	43.15	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	57.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.98	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	47.26	1.75	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	51.49	1.42	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	29.46	1.40	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	45.72	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	52.45	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	35.90	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	38.40	1.67	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	115.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	50.80	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	50.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	47.26	1.52	0.14	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.39	0.52	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	51.91	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	76.22	1.91	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	42.70	1.07	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	54.48	1.50	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.27	1.27	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.58	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.83	1.99	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	62.57	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	32.39	0.85	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	43.26	1.23	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	62.56	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	39.40	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	49.30	2.02	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	53.17	2.47	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	41.39	0.89	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.99	0.99	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	24.19	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.92	0.99	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	54.95	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.92	1.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	28.50	2.13	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.44	1.81	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.15	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	32.98	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	36.88	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	26.26	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.94	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	31.32	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	25.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	106.43	15.30	0.43	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	78.39	5.75	0.00	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	72.09	6.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	80.97	10.43	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	156.87	27.00	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	263.32	11.17	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	43.52	2.04	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	101.07	16.54	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	64.87	2.93	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	97.86	7.44	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	78.10	4.86	0.00	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	121.52	6.94	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	178.16	33.40	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	59.56	4.96	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	95.01	7.85	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	57.35	2.95	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	84.75	4.41	1.14	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	96.60	5.29	0.18	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	56.23	5.83	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	51.63	4.80	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	112.56	16.74	0.33	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	55.62	4.39	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	107.06	6.00	0.53	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	51.34	7.03	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	63.44	6.44	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	75.84	4.82	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	119.68	25.52	0.00	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	171.93	20.23	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	107.83	4.46	0.22	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	60.12	6.35	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	82.60	7.12	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	83.70	4.72	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	54.17	18.06	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	96.63	4.00	0.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	109.56	6.31	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	68.25	4.36	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	59.43	4.64	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	118.81	7.57	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	74.63	8.47	1.30	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	70.16	2.18	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	135.23	14.02	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	68.79	5.29	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	47.20	3.32	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	73.91	2.48	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	77.33	8.04	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	103.74	3.93	2.12	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	113.61	7.51	0.88	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	73.19	3.39	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	20.44	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	71.33	6.10	0.00	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	107.01	12.27	1.26	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	62.04	3.33	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	78.32	7.12	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	116.77	23.81	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	35.41	0.00	0.00
Myoblast, donor1	11241-116D8	114.91	37.52	0.62	1.24
Myoblast, donor2	11322-117D8	91.48	15.73	0.00	1.73
Myoblast, donor3	11398-118D3	91.82	11.44	0.50	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	30.06	1.02	0.15	0.29
Natural Killer Cells, donor1	11230-116C6	46.13	1.85	0.62	1.54
Natural Killer Cells, donor2	11311-117C6	56.09	4.22	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	46.75	3.87	1.84	0.18
Neural stem cells, donor1	11275-116H6	56.26	3.27	0.73	1.45
Neural stem cells, donor2	11352-117H2	51.99	3.85	0.00	5.78
Neurons, donor1	11494-119E9	42.10	6.83	0.00	4.55
Neurons, donor2	11574-120E8	48.44	2.20	0.00	5.06
Neurons, donor3	11655-122E8	28.78	2.47	0.82	8.22
Neutrophils, donor1	11233-116C9	43.62	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	28.99	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	88.57	5.50	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	123.96	9.26	0.12	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	51.45	5.86	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	87.84	2.61	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	97.87	7.30	0.83	2.20
Olfactory epithelial cells, donor2	11934-125I8	86.41	13.90	0.29	2.03
Olfactory epithelial cells, donor3	11935-125I9	72.87	8.06	0.57	1.59
Olfactory epithelial cells, donor4	11936-126A1	144.44	10.32	1.07	1.75
Oligodendrocyte - precursors, donor1	11496-119F2	83.65	10.23	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	58.70	10.63	0.00	1.06
Osteoblast - differentiated, donor2	11353-117H3	19.43	2.29	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	35.38	4.34	0.00	0.62
Osteoblast, donor1	11277-116H8	54.14	6.45	0.39	0.98
Osteoblast, donor2	11354-117H4	141.17	22.47	0.00	1.40
Osteoblast, donor3	11426-118G4	143.07	20.97	0.00	1.24
Pancreatic stromal cells, donor1	11249-116E7	104.54	17.27	0.34	1.68
Pericytes, donor1	11491-119E6	16.47	0.22	0.11	0.56
Pericytes, donor2	11571-120E5	27.39	0.91	0.00	1.13
Pericytes, donor3	11652-122E5	43.74	5.09	0.20	1.02
Perineurial Cells, donor1	11499-119F5	140.15	13.79	0.57	1.81
Perineurial Cells, donor2	11579-120F4	100.29	21.71	0.28	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	55.46	2.23	0.32	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.14	0.73	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.44	1.81	0.26	0.26
Placental Epithelial Cells, donor1	11278-116H9	11.48	0.96	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	16.63	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.79	1.96	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	90.51	11.71	0.00	1.90
Preadipocyte - breast, donor1	11467-119B9	106.36	20.07	0.19	2.81
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	239.78	60.43	2.48	3.65
Preadipocyte - breast, donor2	11328-117E5	122.26	23.42	0.68	2.93
Preadipocyte - omental, donor1	11468-119C1	109.33	21.84	0.00	2.66
Preadipocyte - omental, donor2	11329-117E6	149.71	30.55	0.44	2.62
Preadipocyte - omental, donor3	11403-118D8	142.10	24.50	0.00	2.72
Preadipocyte - perirenal, donor1	11469-119C2	69.88	16.73	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	87.53	24.88	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	134.40	26.56	0.35	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	111.71	25.54	0.17	1.53
Preadipocyte - visceral, donor1	11280-116I2	152.02	29.16	0.47	2.05
Preadipocyte - visceral, donor2	11357-117H7	114.12	20.71	0.00	1.84
Preadipocyte - visceral, donor3	11429-118G7	100.94	14.11	0.31	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	65.92	17.35	0.30	0.00
Prostate Epithelial Cells, donor2	11331-117E8	42.93	6.23	0.27	0.41
Prostate Epithelial Cells, donor3	11404-118D9	35.15	1.22	0.06	1.47
Prostate Stromal Cells, donor1	11254-116F3	98.64	18.11	0.11	1.59
Prostate Stromal Cells, donor2	11332-117E9	93.24	12.37	0.36	0.72
Prostate Stromal Cells, donor3	11405-118E1	78.73	9.49	0.21	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.52	0.73	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	68.62	1.39	0.14	1.39
Renal Epithelial Cells, donor1	11517-119H5	19.27	0.51	0.00	1.52
Renal Epithelial Cells, donor2	11597-120H4	14.23	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	86.28	1.69	0.21	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.83	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	45.69	1.89	0.40	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	100.13	9.99	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.30	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	33.01	0.44	0.22	0.66
Renal Mesangial Cells, donor2	11598-120H5	40.13	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.87	0.28	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	44.02	1.61	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.13	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	24.30	1.93	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	106.56	3.37	0.00	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.27	0.85	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	34.99	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	42.65	1.25	0.00	3.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	54.92	8.29	0.80	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	63.43	6.25	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	32.47	6.05	1.10	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	66.13	4.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	147.58	3.12	0.26	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	75.47	4.27	0.00	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	97.04	8.92	0.89	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	110.27	5.46	0.62	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	73.77	5.71	0.47	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	92.22	7.17	0.69	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	104.60	2.74	0.41	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	71.70	5.14	0.15	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	93.54	5.55	0.18	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	99.13	4.16	0.43	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	73.51	4.83	0.11	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	87.62	5.09	0.44	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	101.51	4.21	0.00	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	87.76	6.52	0.28	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	97.90	6.01	0.75	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	136.02	5.71	0.40	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	81.67	4.67	0.39	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	79.82	5.16	0.76	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	119.40	5.77	0.11	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	83.81	5.89	0.84	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	99.29	5.30	0.68	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	139.67	4.01	0.36	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	69.66	4.54	0.49	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	83.82	4.84	0.54	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	100.95	3.77	0.47	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	80.56	2.98	0.99	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	96.11	5.38	0.23	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	101.81	3.53	0.62	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	90.70	5.31	0.44	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	99.85	6.27	0.84	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	105.11	6.59	0.94	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	123.46	6.47	0.34	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	101.60	5.78	0.39	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	94.05	3.95	0.17	3.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	113.16	9.33	0.14	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	92.92	7.39	0.82	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	100.21	3.07	0.68	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	89.81	5.33	0.30	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	84.76	6.13	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	87.52	3.59	0.83	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	62.62	5.00	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	89.89	7.26	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	59.14	4.14	0.19	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.85	5.59	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	51.98	5.74	0.60	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.83	2.81	0.12	2.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	99.41	10.92	1.16	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	62.67	4.87	0.00	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	49.43	5.43	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.05	4.75	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	62.00	4.49	0.90	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	57.86	3.07	0.35	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	46.53	5.76	0.43	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	67.91	6.01	1.20	2.40
Schwann Cells, donor1	11498-119F4	36.86	0.38	0.38	0.94
Schwann Cells, donor2	11578-120F3	54.44	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	81.72	6.35	0.00	1.97
Sebocyte, donor1	11220-116B5	53.13	3.29	0.55	1.10
Sebocyte, donor2	11301-117B5	26.19	2.30	0.00	0.46
Sebocyte, donor3	11378-118B1	29.06	4.12	0.00	0.62
Sertoli Cells, donor1	11255-116F4	142.47	14.91	0.00	3.31
Sertoli Cells, donor2	11333-117F1	67.78	8.47	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	55.87	1.85	0.09	2.90
Skeletal Muscle Cells, donor2	11358-117H8	19.52	0.72	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	49.33	4.18	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	114.21	10.68	0.16	1.57
Skeletal Muscle Cells, donor5	11455-119A6	117.73	8.47	0.30	1.49
Skeletal Muscle Cells, donor6	11459-119B1	131.12	6.16	1.08	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	151.71	23.19	0.88	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	141.98	15.98	0.57	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	116.47	10.42	0.50	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	75.83	8.43	0.17	2.02
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	41.25	1.45	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	69.21	5.23	0.28	0.83
Skin - palm, donor1	10286-104F7	94.01	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	34.60	2.16	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	129.23	17.18	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.90	2.08	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	56.30	4.59	0.00	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	55.42	3.09	0.14	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	95.78	10.57	1.69	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	57.56	2.77	0.00	1.57
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	83.01	5.86	0.00	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	160.08	24.23	1.11	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	114.04	17.05	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	68.29	9.94	0.66	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	64.97	13.78	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	142.15	20.09	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	51.04	5.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	93.69	17.17	0.13	1.60
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	98.19	19.28	0.22	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	240.83	33.54	0.38	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	105.17	13.35	0.33	3.26
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	122.86	15.36	1.77	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	101.08	19.50	0.14	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.17	0.81	0.00	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	77.02	9.44	0.00	3.65
Smooth Muscle Cells - Carotid, donor1	11285-116I7	84.86	12.38	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	74.39	8.11	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	109.13	12.98	0.88	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	112.35	16.36	0.00	1.72
Smooth Muscle Cells - Colonic, donor3	11396-118D1	117.13	17.00	0.21	1.47
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	59.24	11.60	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	63.59	18.32	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	108.48	12.85	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	27.99	0.68	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	115.28	9.89	0.24	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	130.63	24.46	0.10	2.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	88.52	15.70	0.23	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	79.70	10.26	0.00	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	108.88	8.74	0.00	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	140.75	13.18	0.13	2.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	81.89	15.03	0.75	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	81.68	10.65	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	128.61	34.68	0.30	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	66.01	9.75	0.00	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	123.71	22.32	0.00	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	73.71	12.62	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	88.06	13.79	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	24.48	3.24	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	128.88	11.66	0.33	1.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	112.59	11.21	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	103.91	13.24	0.14	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	74.70	11.47	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	73.33	5.45	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	129.40	14.81	0.28	1.96
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	119.57	18.43	0.00	1.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.09	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	91.26	16.88	0.00	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	142.07	16.79	1.10	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	108.25	11.12	0.00	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	73.47	8.94	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	62.41	8.73	0.00	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	61.00	11.53	0.74	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	86.24	16.17	0.36	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	71.26	9.94	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	107.13	12.60	0.79	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	75.68	10.92	0.25	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	97.83	9.98	0.40	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	58.10	5.43	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	66.92	5.50	0.00	0.46
Synoviocyte, donor1	11291-117A4	133.82	28.11	0.17	2.19
Synoviocyte, donor2	11368-117I9	55.65	7.38	0.00	0.17
Synoviocyte, donor3	11440-118H9	50.94	3.57	0.00	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	24.66	3.22	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.24	2.55	0.23	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	38.85	1.00	0.14	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	25.13	1.16	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	1.72	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	55.61	8.73	0.98	0.98
Urethra, donor2	10319-105A4	102.51	5.40	1.80	1.80
Urothelial Cells, donor1	11520-119H8	16.74	0.53	0.53	0.53
Urothelial Cells, donor2	11600-120H7	14.82	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	12.15	0.69	0.00	0.46
Urothelial cells, donor0	11216-116B1	113.68	3.79	0.45	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	58.73	3.56	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	88.64	1.43	0.00	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.96	0.68	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	53.37	2.41	1.03	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	0.58	1.16	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	79.13	3.12	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	68.83	3.67	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	93.14	12.71	0.12	0.37
Wilms' tumor cell line:HFWT	10597-108E3	114.41	6.16	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.22	4.47	0.28	0.28
achilles tendon, donor2	10292-104G4	49.60	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	37.22	3.82	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.99	1.39	0.00	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	42.26	3.44	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	44.90	1.09	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	43.57	0.56	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.95	1.90	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.56	1.63	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	28.20	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	0.82	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	26.02	3.11	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.58	0.18	0.00	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.65	1.16	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	26.41	2.07	1.04	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	24.55	0.00	0.88	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.89	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	68.68	0.82	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.19	0.31	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.52	0.43	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.04	0.00	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	12.04	0.96	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.94	1.11	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	33.69	0.67	0.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.98	0.00	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	51.90	2.18	0.44	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	42.39	4.24	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	81.44	7.45	0.78	2.02
adipose, donor1	10184-103D4	68.02	2.93	1.17	0.00
adipose, donor2	10185-103D5	44.20	2.84	0.00	0.41
adipose, donor3	10186-103D6	46.56	3.00	0.00	0.00
adipose, donor4	10187-103D7	43.34	5.20	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	84.59	4.10	0.63	1.26
adrenal gland, adult, pool1	10081-102A9	50.93	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	25.48	0.27	0.27	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	37.16	3.57	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	77.67	9.51	0.00	1.85
amniotic membrane cells, donor2	12236-129G4	65.25	4.73	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	65.40	3.54	0.00	0.29
amygdala - adult, donor10196	10167-103B5	61.66	0.00	0.00	2.37
amygdala, adult, donor10252	10151-102I7	38.73	2.64	1.01	5.47
amygdala, newborn, donor10223	10360-105E9	26.47	2.90	0.65	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	120.07	3.82	0.76	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	49.64	2.21	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	141.63	2.67	2.00	0.00
aorta, adult, pool1	10052-101G7	112.97	8.04	1.57	2.35
appendix, adult	10189-103D9	74.52	6.60	0.39	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	41.27	2.06	0.69	1.38
artery, adult	10190-103E1	54.35	2.72	0.00	6.79
astrocytoma cell line:TM-31	10425-106D2	218.89	2.17	0.87	2.32
b cell line:RPMI1788	10427-106D4	63.35	1.93	1.93	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	202.26	37.18	0.83	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	27.69	1.29	0.20	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	37.83	4.35	0.67	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.69	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	114.51	5.76	0.65	4.89
blood, adult, pool1	10053-101G8	35.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	149.00	16.27	0.00	0.86
bone marrow, adult	10192-103E3	62.76	8.10	0.67	2.70
brain, adult, donor1	10084-102B3	67.65	3.08	1.03	4.10
brain, adult, pool1	10012-101C3	54.34	3.45	0.11	9.13
brain, fetal, pool1	10085-102B4	66.78	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	39.31	2.31	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	42.69	1.37	0.25	1.62
breast, adult, donor1	10080-102A8	63.77	5.05	1.26	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	43.57	0.38	0.25	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	104.21	2.16	0.31	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	107.51	5.30	1.38	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	26.63	1.21	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	92.62	3.29	0.47	2.82
carcinoid cell line:NCI-H727	10735-110B6	18.81	1.53	0.11	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	63.38	1.90	0.63	3.49
carcinosarcoma cell line:JHUCS-1	10642-109A3	81.72	1.86	0.27	2.40
caudate nucleus - adult, donor10196	10177-103C6	84.05	3.45	0.00	5.76
caudate nucleus, adult, donor10252	10164-103B2	63.92	1.67	0.33	2.68
caudate nucleus, adult, donor10258	10379-105H1	87.88	2.29	0.00	4.58
caudate nucleus, newborn, donor10223	10354-105E3	57.50	1.46	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	136.92	11.65	0.00	11.65
cerebellum, adult, donor10252	10166-103B4	73.87	5.98	1.71	12.81
cerebellum, adult, pool1	10083-102B2	55.54	1.72	0.69	6.90
cerebellum, newborn, donor10223	10357-105E6	71.40	12.45	0.83	4.98
cerebral meninges, adult	10188-103D8	63.03	4.29	0.50	6.05
cerebrospinal fluid, donor2	10294-104G6	45.31	0.73	0.00	2.19
cervical cancer cell line:D98-AH2	10552-107I3	31.78	2.01	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	15.08	0.66	0.50	2.32
cervix, adult, pool1	10013-101C4	97.43	6.51	1.47	7.45
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	84.72	4.88	1.53	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	126.71	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	30.07	0.50	0.25	1.24
choriocarcinoma cell line:SCH	10785-110H2	40.66	0.37	0.12	1.97
choriocarcinoma cell line:T3M-3	10618-108G6	14.23	0.00	0.47	0.47
chorionic membrane cells, donor1	12238-129G6	62.11	3.70	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	144.47	17.70	0.00	1.59
chorionic membrane cells, donor3	12240-129G8	72.53	6.59	0.55	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	14.14	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	39.00	3.27	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.08	0.42	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	20.03	0.77	0.26	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.83	0.97	0.00	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	19.34	0.20	0.00	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	18.85	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	38.57	1.04	0.52	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	93.95	0.69	0.46	1.37
clear cell carcinoma cell line:TEN	10636-108I6	65.06	2.43	0.17	1.39
colon carcinoma cell line:CACO-2	10513-107D9	68.82	11.53	1.10	0.55
colon carcinoma cell line:COLO-320	10420-106C6	63.47	16.72	0.00	0.00
colon, adult, donor1	10082-102B1	90.44	20.23	1.19	0.00
colon, adult, pool1	10014-101C5	109.87	29.14	1.29	3.17
colon, fetal, donor1	10070-101I7	93.93	12.98	3.71	2.47
common myeloid progenitor CMP, donor1	12130-128D6	201.67	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.47	1.70	0.00	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.36	3.17	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	38.21	3.53	0.85	0.85
corpus callosum, adult, pool1	10042-101F6	45.77	2.32	1.11	4.86
cruciate ligament, donor2	10295-104G7	71.32	9.73	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	97.91	5.62	2.41	1.61
diencephalon, adult	10193-103E4	53.04	2.16	0.24	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.08	0.69	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.29	0.51	0.00	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	46.70	6.02	0.24	0.48
ductus deferens, adult	10196-103E7	60.30	2.99	0.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	70.57	23.04	5.76	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	83.13	16.18	4.41	2.21
dura mater, adult, donor1	10041-101F5	88.86	5.62	1.24	4.29
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	48.86	6.88	0.44	5.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	55.74	6.45	0.29	2.29
embryonic pancreas cell line:1B2C6	10604-108F1	101.12	1.85	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	88.69	2.72	0.00	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	85.52	2.16	0.00	0.93
embryonic pancreas cell line:2C6	10603-108E9	97.20	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	54.64	3.02	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	109.65	1.81	0.18	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	51.46	1.61	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	59.14	4.34	0.00	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	56.75	2.53	0.66	0.99
epididymis, adult	10197-103E8	68.24	4.81	0.84	3.77
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	49.32	0.89	1.06	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	71.57	3.54	0.00	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	49.01	9.83	0.79	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	47.83	7.68	0.20	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.37	10.42	1.12	1.23
esophagus, adult, pool1	10015-101C6	71.46	5.73	0.64	1.91
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	78.77	9.27	0.38	1.38
eye - muscle inferior rectus, donor1	10272-104E2	53.12	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	86.27	2.10	0.00	4.21
eye - muscle medial, donor2	10299-104H2	65.48	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	58.47	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	64.13	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	70.17	3.31	0.51	3.81
fibrosarcoma cell line:HT-1080	10758-110E2	33.59	0.26	0.38	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	60.54	0.95	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	78.25	4.41	1.13	8.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	69.96	6.61	0.90	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	113.47	2.19	0.00	0.82
gall bladder, adult	10198-103E9	63.26	3.62	0.72	3.38
gamma delta positive T cells, donor1	11937-126A2	56.37	2.15	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	40.71	2.99	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.49	2.53	0.42	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.95	3.29	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	83.29	6.56	0.82	0.82
gastric cancer cell line:GSS	10560-108A2	58.57	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	68.99	5.03	0.91	2.06
giant cell carcinoma cell line:LU65	10487-107B1	24.78	0.46	0.34	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	67.60	5.32	0.14	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	31.18	2.24	0.25	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	66.60	4.01	0.11	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	75.70	4.35	0.14	1.12
glioblastoma cell line:T98G	10485-107A8	52.87	8.50	0.22	0.66
glioma cell line:GI-1	10413-106B8	73.81	3.81	0.00	1.46
globus pallidus - adult, donor10196	10175-103C4	69.25	0.73	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	50.77	2.69	0.98	1.46
globus pallidus, adult, donor10258	10367-105F7	49.29	4.11	2.74	2.74
globus pallidus, newborn, donor10223	10364-105F4	36.24	2.66	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	141.93	9.79	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	157.12	10.88	0.00	0.96
hIPS +CCl2, biol_rep1	14383-156B9	47.75	1.84	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	46.18	2.74	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	50.88	1.93	0.00	0.00
hIPS, biol_rep1	14380-156B6	63.24	4.31	0.00	0.00
hIPS, biol_rep2	14381-156B7	50.75	2.74	0.00	0.69
hIPS, biol_rep3	14382-156B8	50.76	2.21	0.00	5.52
hairy cell leukemia cell line:Mo	10712-109I1	35.34	0.29	0.00	0.29
heart - mitral valve, adult	10205-103F7	89.39	11.06	2.09	2.69
heart - pulmonic valve, adult	10206-103F8	78.44	6.28	1.57	3.14
heart - tricuspid valve, adult	10207-103F9	57.45	8.33	0.83	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	64.89	2.04	0.61	1.63
heart, adult, diseased, donor1	10051-101G6	80.91	4.68	0.43	1.70
heart, adult, pool1	10016-101C7	89.00	2.99	0.23	2.76
heart, fetal, pool1	10046-101G1	116.64	6.98	1.13	5.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	238.49	22.83	0.00	3.70
hepatoblastoma cell line:HuH-6	10633-108I3	79.67	16.65	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	326.07	92.04	2.10	2.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	319.70	94.55	1.34	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	331.05	96.51	3.23	2.22
hepatoma cell line:Li-7	10484-107A7	47.82	3.67	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	25.02	0.20	0.20	1.01
hippocampus - adult, donor10196	10169-103B7	50.16	7.57	0.95	6.62
hippocampus, adult, donor10252	10153-102I9	36.74	2.45	0.82	2.86
hippocampus, adult, donor10258	10374-105G5	67.22	0.50	0.00	2.99
hippocampus, newborn, donor10223	10363-105F3	41.24	2.82	0.35	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	59.81	4.27	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	35.15	3.14	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.88	1.78	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.76	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.86	2.07	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.20	2.66	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	42.33	3.21	0.58	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	43.73	3.23	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	36.29	3.34	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	60.62	4.74	0.00	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	51.75	4.98	0.32	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	68.00	4.04	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	35.05	4.07	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	39.30	2.46	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.93	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	30.35	2.29	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	35.32	1.74	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	2.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	42.58	2.07	0.94	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	40.47	1.36	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	51.68	2.51	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	52.26	4.90	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	57.48	2.90	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	59.19	5.38	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	35.47	4.25	0.37	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	34.23	3.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	63.70	7.76	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.08	3.52	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	34.52	2.22	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	35.10	3.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	45.51	1.03	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	50.48	1.99	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.35	4.36	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	59.57	4.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	69.66	8.33	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	56.79	10.75	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	37.19	2.66	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	34.76	4.90	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	34.15	3.41	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.23	2.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	110.61	13.01	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	48.65	3.31	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	50.90	2.19	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.04	2.53	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	39.86	1.78	0.36	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	54.90	5.97	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	83.96	5.28	0.81	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	64.12	7.54	0.54	0.27
immature langerhans cells, donor1	11904-125F5	43.83	4.84	0.48	0.73
immature langerhans cells, donor2	11905-125F6	26.14	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	88.48	3.22	0.28	8.14
keratoacanthoma cell line:HKA-1	10791-110H8	30.56	0.33	0.33	0.65
kidney, adult, pool1	10017-101C8	57.17	5.81	1.20	0.90
kidney, fetal, pool1	10045-101F9	55.03	2.83	0.21	1.84
large cell lung carcinoma cell line:IA-LM	10509-107D5	156.08	7.95	2.13	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	47.83	3.18	0.00	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.31	1.28	0.00	2.02
left atrium, adult, donor1	10079-102A7	101.89	4.90	1.09	2.18
left ventricle, adult, donor1	10078-102A6	66.24	3.03	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	115.19	19.15	0.27	0.82
leiomyoma cell line:10964C	10569-108B2	44.55	6.47	0.00	1.08
leiomyoma cell line:15242A	10570-108B3	35.87	5.43	0.00	0.00
leiomyoma cell line:15425	10571-108B4	69.45	10.68	0.00	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	114.29	6.35	0.00	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	54.37	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	30.10	2.01	0.35	1.06
liposarcoma cell line:KMLS-1	10782-110G8	84.51	8.59	0.47	0.78
liposarcoma cell line:SW 872	10726-110A6	111.12	9.99	0.12	1.95
liver, adult, pool1	10018-101C9	131.76	47.97	0.49	1.13
liver, fetal, pool1	10086-102B5	77.14	7.53	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	39.08	5.10	0.73	6.27
locus coeruleus, adult, donor10252	10165-103B3	45.03	4.61	1.66	4.43
locus coeruleus, adult, donor10258	10375-105G6	38.09	1.97	1.13	4.51
locus coeruleus, newborn, donor10223	10362-105F2	31.55	4.21	0.00	3.79
lung adenocarcinoma cell line:A549	10499-107C4	106.84	5.12	0.55	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	21.37	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	181.12	8.44	1.05	1.98
lung, adult, pool1	10019-101D1	53.28	1.42	0.47	0.95
lung, fetal, donor1	10068-101I5	108.45	4.00	2.85	3.14
lung, right lower lobe, adult, donor1	10075-102A3	48.11	1.83	1.37	2.75
lymph node, adult, donor1	10077-102A5	49.23	1.89	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	61.37	0.88	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	24.60	2.11	0.45	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	20.39	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	166.50	10.21	0.89	2.66
mature adipocyte, donor2	12232-129F9	141.95	17.85	0.42	0.62
mature adipocyte, donor3	12233-129G1	130.86	23.94	1.19	0.95
mature adipocyte, donor4	12234-129G2	157.40	19.48	1.05	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.21	0.48	0.00	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	92.50	7.90	0.00	13.54
medial frontal gyrus, adult, donor10252	10150-102I6	49.47	5.52	0.55	9.01
medial frontal gyrus, adult, donor10258	10368-105F8	92.45	4.13	0.64	5.72
medial frontal gyrus, newborn, donor10223	10352-105E1	68.24	4.26	1.28	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	61.09	3.88	0.34	7.59
medial temporal gyrus, adult, donor10252	10156-103A3	44.14	3.61	0.64	5.73
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	67.42	1.93	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	14.35	28.71	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	42.71	3.23	0.00	1.79
medulla oblongata - adult, donor10196	10174-103C3	64.90	3.89	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	43.96	4.02	0.93	3.10
medulla oblongata, adult, pool1	10038-101F2	55.02	3.59	0.33	6.37
medulla oblongata, newborn, donor10223	10361-105F1	33.33	1.74	0.69	2.43
medulloblastoma cell line:D283 Med	10838-111E1	59.56	3.54	1.11	3.32
medulloblastoma cell line:ONS-76	10759-110E3	68.84	2.69	0.00	1.10
melanoma cell line:COLO 679	10514-107E1	32.63	1.01	0.14	0.57
melanoma cell line:G-361	10465-106H6	40.99	2.44	0.27	1.90
meningioma cell line:HKBMM	10691-109F7	81.95	2.71	0.54	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	17.62	0.88	1.76	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	21.00	1.30	0.00	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	157.58	32.53	0.15	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	94.89	14.72	0.18	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	94.42	17.81	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	77.68	7.02	0.14	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	99.94	11.17	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	116.61	13.88	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.24	6.18	0.17	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	92.47	12.77	0.46	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	105.18	23.21	0.13	1.86
mesenchymal precursor cell - cardiac, donor4	11755-123G9	106.01	19.18	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	139.28	15.65	0.57	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	54.67	5.27	0.00	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	146.12	20.34	0.83	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	120.43	15.01	0.00	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	133.12	17.15	0.41	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	91.66	12.22	0.72	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	99.83	6.10	0.31	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	81.62	13.45	0.68	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	112.02	12.17	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	133.90	14.64	0.15	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	117.47	7.88	0.09	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	93.51	4.42	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	111.89	13.74	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	81.26	5.05	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	125.13	15.07	0.00	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	109.73	16.88	0.26	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	122.76	19.63	0.00	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	119.54	15.40	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	107.09	15.53	0.24	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	126.58	16.25	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	128.89	18.47	0.00	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	120.94	19.46	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	140.75	16.15	0.00	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	130.07	18.07	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	122.34	18.27	0.00	2.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	180.40	19.80	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	112.45	19.47	0.00	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	109.71	18.42	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	113.40	18.90	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	123.05	21.88	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	20.66	0.00	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	160.44	16.89	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	120.76	18.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	149.26	22.39	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	122.67	17.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	120.50	18.66	0.39	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	117.53	12.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	111.27	20.86	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	133.48	28.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	141.72	19.57	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	130.38	25.59	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	145.04	19.00	0.00	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	97.61	9.66	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	88.12	15.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	50.93	7.74	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	57.20	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	52.47	11.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	63.28	6.86	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	60.15	16.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	73.33	20.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	92.45	7.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	71.59	13.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	91.54	37.11	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	67.29	26.92	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	67.42	22.26	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	53.60	25.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	17.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	8.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	86.18	15.17	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	18.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	62.60	26.36	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	84.93	13.69	0.60	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	67.17	11.03	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	56.02	8.15	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	155.52	13.93	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	155.92	2.83	0.94	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	73.67	10.43	1.62	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	58.57	7.60	0.31	1.23
mesothelioma cell line:Mero-25	10850-111F4	27.46	2.50	0.23	0.68
mesothelioma cell line:Mero-41	10851-111F5	61.85	8.31	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	49.60	3.10	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	44.68	4.20	0.53	0.79
mesothelioma cell line:Mero-83	10854-111F8	78.30	8.51	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	48.03	7.08	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	57.35	4.55	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	62.45	3.64	0.17	1.66
mesothelioma cell line:NCI-H226	10846-111E9	48.87	6.88	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	37.92	4.27	0.00	0.51
mesothelioma cell line:NCI-H28	10845-111E8	21.63	2.29	0.00	0.51
mesothelioma cell line:No36	10857-111G2	35.56	2.61	0.00	1.30
mesothelioma cell line:ONE58	10858-111G3	40.10	4.34	0.27	1.90
migratory langerhans cells, donor1	11901-125F2	62.37	0.38	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	76.44	1.71	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	71.43	0.54	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	113.94	0.65	0.00	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	244.79	7.63	0.64	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	59.20	1.15	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.07	1.71	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	34.93	1.29	0.55	2.59
myeloma cell line:PCM6	10474-106I6	31.23	0.40	1.19	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	189.22	12.68	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	87.28	5.49	0.00	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	48.92	1.23	0.00	2.90
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.27	2.28	0.07	2.57
nasal epithelial cells, donor2	12227-129F4	37.54	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	79.14	4.37	1.84	4.14
neuroblastoma cell line:NB-1	10539-107G8	85.69	5.05	0.19	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	35.43	1.90	0.42	1.90
neuroblastoma cell line:NH-12	10555-107I6	48.64	2.80	0.93	6.89
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	39.62	0.95	0.47	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.36	0.63	0.48	2.85
neuroectodermal tumor cell line:TASK1	10774-110F9	62.59	1.01	0.20	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	51.50	1.27	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	170.08	23.16	0.00	3.73
neutrophil PMN, donor1	12133-128D9	148.75	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	87.77	5.75	0.85	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.81	1.60	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	113.17	16.35	0.00	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	80.41	9.20	0.53	1.84
nucleus accumbens, adult, pool1	10037-101F1	91.58	3.37	0.66	7.50
occipital cortex - adult, donor10196	10172-103C1	105.08	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	45.89	2.15	0.27	6.17
occipital cortex, newborn, donor10223	10355-105E4	44.40	1.09	0.00	2.55
occipital lobe, adult, donor1	10076-102A4	85.02	2.10	0.26	7.08
occipital lobe, fetal, donor1	10073-102A1	111.57	2.57	0.86	3.00
occipital pole, adult, pool1	10036-101E9	62.99	2.92	0.08	8.75
olfactory region, adult	10195-103E6	48.34	2.48	0.76	6.69
optic nerve, donor1	10277-104E7	48.03	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	36.22	3.30	0.68	1.71
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	76.25	0.55	0.27	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	40.98	1.35	0.68	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.95	1.27	0.00	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	121.41	7.64	0.59	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	85.02	1.87	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	81.01	12.09	0.21	1.27
ovary, adult, pool1	10020-101D2	87.88	3.93	0.09	7.77
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	192.30	4.40	0.37	1.28
pancreas, adult, donor1	10049-101G4	33.86	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	9.50	0.00	0.28	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	35.77	1.87	0.00	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	86.10	1.66	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	87.50	3.75	0.46	7.50
parietal cortex, adult, donor10258	10373-105G4	56.52	0.73	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	82.76	2.82	1.88	3.76
parietal lobe, adult, donor10252	10157-103A4	51.88	3.99	1.14	6.27
parietal lobe, adult, pool1	10034-101E7	81.42	3.00	0.35	8.11
parietal lobe, fetal, donor1	10072-101I9	111.53	1.94	1.94	8.73
parietal lobe, newborn, donor10223	10356-105E5	40.38	0.37	0.37	1.50
parotid gland, adult	10199-103F1	17.27	3.08	0.00	0.00
penis, adult	10200-103F2	72.51	5.91	1.07	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.82	0.00	0.56	2.60
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	58.13	1.31	0.29	1.60
pineal gland - adult, donor10196	10179-103C8	91.59	7.10	1.94	3.87
pineal gland, adult, donor10252	10160-103A7	130.29	3.55	1.18	5.33
pineal gland, adult, donor10258	10377-105G8	83.40	3.14	1.25	3.76
pituitary gland - adult, donor10196	10180-103C9	89.04	3.04	1.01	3.04
pituitary gland, adult, donor10252	10162-103A9	140.20	4.69	5.21	4.69
pituitary gland, adult, donor10258	10378-105G9	68.95	3.40	1.70	2.55
placenta, adult, pool1	10021-101D3	58.05	2.80	0.32	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	35.89	1.06	0.53	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	75.80	7.00	0.16	1.25
pons, adult, pool1	10033-101E6	80.47	6.02	0.60	6.63
postcentral gyrus, adult, pool1	10032-101E5	72.18	3.92	0.61	9.07
promyelocytes/myelocytes PMC, donor1	12132-128D8	156.85	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	141.58	3.06	0.29	1.60
prostate cancer cell line:PC-3	10439-106E7	130.32	4.90	0.36	1.82
prostate, adult, pool1	10022-101D4	73.19	3.26	0.18	4.44
putamen, adult, donor10196	10176-103C5	94.66	2.12	0.47	3.30
putamen, adult, donor10252	10152-102I8	78.43	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	100.54	0.00	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	77.32	1.45	0.48	3.87
putamen, newborn, donor10223	10365-105F5	44.98	0.75	0.00	4.50
rectal cancer cell line:TT1TKB	10469-106I1	184.45	18.62	0.29	4.07
rectum, fetal, donor1	10067-101I4	123.80	8.35	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	73.99	5.51	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	47.63	0.41	1.24	0.00
retina, adult, pool1	10030-101E3	78.03	5.67	0.70	5.67
retinoblastoma cell line:Y79	10475-106I7	69.89	4.16	1.04	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	176.43	20.78	1.97	1.72
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	86.33	1.69	0.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	182.64	7.58	0.76	0.76
salivary acinar cells, donor1	11771-123I7	42.41	3.88	0.32	0.81
salivary acinar cells, donor2	11772-123I8	32.22	3.17	0.28	1.38
salivary acinar cells, donor3	11773-123I9	48.33	5.96	0.00	0.66
salivary gland, adult, pool1	10093-102C3	29.74	0.57	0.57	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	60.62	1.35	0.08	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	61.48	1.41	0.12	1.65
seminal vesicle, adult	10201-103F3	69.31	4.23	1.06	5.29
serous adenocarcinoma cell line:JHOS-2	10639-108I9	47.13	6.32	0.73	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.73	2.01	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	47.17	1.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.63	1.48	0.67	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	18.46	1.88	0.66	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	26.97	14.84	0.39	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	92.92	2.84	0.00	3.55
skeletal muscle, adult, pool1	10023-101D5	60.45	2.76	0.12	5.04
skeletal muscle, fetal, donor1	10066-101I3	66.33	3.02	2.01	4.02
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	117.41	27.77	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	27.68	0.67	1.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	33.10	7.25	1.58	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	72.28	0.77	0.39	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	34.12	1.15	0.66	1.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	102.78	0.64	2.73	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	47.07	2.40	0.65	2.40
small intestine, adult, pool1	10024-101D6	121.95	77.16	3.11	2.99
small intestine, fetal, donor1	10064-101I1	79.85	18.18	2.46	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	10.77	0.00	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	130.26	9.30	1.29	7.50
somatostatinoma cell line:QGP-1	10781-110G7	14.47	1.07	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	39.69	1.38	1.84	3.21
spinal cord, adult, donor10252	10159-103A6	42.19	2.76	2.37	1.97
spinal cord, adult, donor10258	10369-105F9	36.67	2.77	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	81.11	3.05	1.83	1.83
spinal cord, newborn, donor10223	10359-105E8	36.28	3.67	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	186.39	21.36	0.15	1.79
spleen, adult, pool1	10025-101D7	46.92	1.32	0.55	1.43
spleen, fetal, pool1	10044-101F8	52.28	3.34	0.24	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.29	1.24	0.00	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	45.00	1.33	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.55	0.70	1.05	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	36.75	0.78	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	24.54	1.58	0.11	3.94
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	38.12	0.85	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	87.58	5.08	0.00	3.81
stomach, fetal, donor1	10062-101H8	159.13	5.34	1.07	2.14
submaxillary gland, adult	10202-103F4	43.87	1.14	1.71	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	35.73	1.04	1.66	2.28
substantia nigra, adult, donor10258	10371-105G2	42.93	4.14	0.00	2.59
substantia nigra, newborn, donor10223	10358-105E7	27.56	4.24	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	81.62	2.29	0.46	2.29
temporal lobe, adult, pool1	10031-101E4	68.07	2.37	0.17	6.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	75.50	0.71	0.71	11.40
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	46.15	0.88	1.76	3.08
tenocyte, donor1	11763-123H8	136.50	30.02	0.35	1.75
tenocyte, donor2	11765-123I1	54.94	5.72	0.00	0.76
tenocyte, donor3	11768-123I4	95.63	25.58	0.37	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	52.52	4.25	0.00	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	44.39	3.55	0.46	0.62
teratocarcinoma cell line:PA-1	10807-111A6	55.48	2.79	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	36.43	4.44	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.20	0.76	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	35.23	2.51	0.87	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.84	0.98	0.33	3.58
testis, adult, pool1	10026-101D8	63.03	3.87	0.86	8.16
testis, adult, pool2	10096-102C6	66.76	2.26	1.80	10.37
thalamus - adult, donor10196	10168-103B6	67.34	2.21	0.00	6.62
thalamus, adult, donor10252	10154-103A1	37.04	2.66	1.41	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	78.52	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.16	1.15	0.49	5.60
thalamus, newborn, donor10223	10366-105F6	38.55	4.60	1.15	2.30
throat, adult	10209-103G2	38.70	2.50	0.50	2.50
throat, fetal, donor1	10061-101H7	87.15	7.31	0.61	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	32.39	0.79	0.40	2.19
thymus, adult, pool1	10027-101D9	58.46	1.19	0.10	0.60
thymus, fetal, pool1	10043-101F7	61.30	1.97	1.45	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	91.74	8.11	0.53	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	81.86	3.21	0.42	1.54
thyroid, adult, pool1	10028-101E1	39.10	2.71	0.75	1.31
thyroid, fetal, donor1	10060-101H6	71.98	5.01	2.11	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	3.08	0.00	6.16
tongue, adult	10203-103F5	39.31	2.33	0.00	2.09
tongue, fetal, donor1	10059-101H5	83.94	3.55	1.18	5.12
tonsil, adult, pool1	10047-101G2	47.28	2.70	0.30	2.40
trachea, adult, pool1	10029-101E2	50.72	3.93	0.33	1.96
trachea, fetal, donor1	10058-101H4	81.56	7.31	1.54	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	124.35	19.49	0.00	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	61.70	2.43	0.20	1.62
transitional-cell carcinoma cell line:JMSU1	10492-107B6	90.72	3.45	0.16	2.51
tridermal teratoma cell line:HGRT	10694-109G1	213.08	15.22	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	48.00	5.08	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	91.81	10.43	2.09	2.09
uterus, adult, pool1	10100-102D1	137.70	2.22	1.88	10.07
uterus, fetal, donor1	10055-101H1	151.53	7.17	3.07	1.02
vagina, adult	10204-103F6	64.62	5.82	0.65	0.65
vein, adult	10191-103E2	56.77	5.04	0.44	2.85
xeroderma pigentosum b cell line:XPL 17	10563-108A5	29.37	0.53	0.27	0.27